DE69618511D1 - Gammainterferon enthaltende Zusammensetzung zur Prurigo-Behandlung - Google Patents

Gammainterferon enthaltende Zusammensetzung zur Prurigo-Behandlung

Info

Publication number
DE69618511D1
DE69618511D1 DE69618511T DE69618511T DE69618511D1 DE 69618511 D1 DE69618511 D1 DE 69618511D1 DE 69618511 T DE69618511 T DE 69618511T DE 69618511 T DE69618511 T DE 69618511T DE 69618511 D1 DE69618511 D1 DE 69618511D1
Authority
DE
Germany
Prior art keywords
prurigo
gamma
treatment
ifn
containing composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69618511T
Other languages
English (en)
Other versions
DE69618511T2 (de
Inventor
Masahiro Takigawa
Yoshiki Tokura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asubio Pharma Co Ltd
Original Assignee
Suntory Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Suntory Ltd filed Critical Suntory Ltd
Application granted granted Critical
Publication of DE69618511D1 publication Critical patent/DE69618511D1/de
Publication of DE69618511T2 publication Critical patent/DE69618511T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
DE69618511T 1995-09-07 1996-09-06 Gammainterferon enthaltende Zusammensetzung zur Prurigo-Behandlung Expired - Fee Related DE69618511T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP26458295A JP3834084B2 (ja) 1995-09-07 1995-09-07 痒疹治療剤

Publications (2)

Publication Number Publication Date
DE69618511D1 true DE69618511D1 (de) 2002-02-21
DE69618511T2 DE69618511T2 (de) 2002-08-01

Family

ID=17405301

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69618511T Expired - Fee Related DE69618511T2 (de) 1995-09-07 1996-09-06 Gammainterferon enthaltende Zusammensetzung zur Prurigo-Behandlung

Country Status (6)

Country Link
US (1) US5972365A (de)
EP (1) EP0761228B1 (de)
JP (1) JP3834084B2 (de)
AT (1) ATE211919T1 (de)
DE (1) DE69618511T2 (de)
ES (1) ES2171585T3 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004058295A1 (ja) * 2002-12-26 2004-07-15 Daiichi Suntory Pharma Co., Ltd. 類天疱瘡治療剤
US8490578B2 (en) 2009-10-13 2013-07-23 Pet Care Systems, Inc. Clumped sorbent material

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL76591A0 (en) * 1984-10-05 1986-02-28 Bioferon Biochem Substanz Pharmaceutical compositions containing ifn-ypsilon and processes for the preparation thereof
DE3531597A1 (de) * 1985-09-04 1987-03-05 Bioferon Biochem Substanz Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur behandlung psoriatischer erkrankungen
CA1340698C (en) * 1986-07-25 1999-08-10 Kabushiki Kaisha Hayashibara Seibutsu Kaguku Kenkyujo Preparation and uses of interferon-gamma
JP2901017B2 (ja) * 1989-12-01 1999-06-02 チルドレンズ・メデイカル・センター・コーポレーシヨン γインターフエロンによるアトピー性疾患の処置
US5200177A (en) * 1989-12-01 1993-04-06 The Children's Medical Center Corporation Treatment of atopic disorders with gamma-interferon
TW218846B (de) * 1992-04-07 1994-01-11 Ciba Geigy

Also Published As

Publication number Publication date
ES2171585T3 (es) 2002-09-16
EP0761228B1 (de) 2002-01-16
DE69618511T2 (de) 2002-08-01
JPH0971538A (ja) 1997-03-18
JP3834084B2 (ja) 2006-10-18
US5972365A (en) 1999-10-26
EP0761228A2 (de) 1997-03-12
EP0761228A3 (de) 1997-06-25
ATE211919T1 (de) 2002-02-15

Similar Documents

Publication Publication Date Title
GEP20002146B (en) Therapeutic Peptide Derivatives
GR3031448T3 (en) Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine.
CA2181048A1 (en) A method for sustained and extended corneal analgesia
KR100321467B1 (de)
KR930702022A (ko) 인슐린의 경구 투여에 의한 타잎 1 당뇨병의 치료 또는 예방법
RU92004521A (ru) Применение бисфосфонатов и экстракта паращитовидных желез для лечения остеопороза и набор для лечения
HU913447D0 (en) Medical preparations and their use in treating neurologic disorders
DE3583849D1 (de) Verwendung von interferon-gamma (ifn-gamma) enthaltenden praeparationen zur systemischen behandlung von verschiedenen erkrankungen des menschen in niedriger dosierung.
RU95113492A (ru) Терапевтическая комбинация, содержащая человеческий интерферон, его применение, фармацевтический препарат, упаковка и способ лечения
IL103303A (en) Pharmaceutical compositions containing ibuprofen and codeine for relief of chronic pain
ES2175333T3 (es) Nueva administracion de trombopoyetina.
ZA898667B (en) Use of acetyl l-carnitine in the therapeutic treatment of cataract and pharmaceutical compositions useful in such treatment
NO931886L (no) Anvendelse av aica ribocid-forbindelser for behandling/prevensjon av vevskader som skyldes nedsatt blodstroemning
DK0629400T3 (da) Idebenon-holdige præparater til behandling af Alzheimer's syge
ZA95150B (en) Application of riluzole in the treatment of mitochondrial diseases
DE69618511D1 (de) Gammainterferon enthaltende Zusammensetzung zur Prurigo-Behandlung
HK1005168A1 (en) Use of superoxide dismutase for the preparation of drugs for the prophylaxis and/or treatment of organ failure in risk patients having a polytrauma due to an accident
KR950702433A (ko) Tcf-ii를 유효성분으로 하는 혈장 응고 정상화제
KR870010871A (ko) 재조합 인체 알파 인터페론에 의한 기저세포 암종의 병소내적 치료방법
KR900701311A (ko) 재조합 사람 α-인터페론을 병소내로 투여하여 편평세포 암을 치료하는 방법
KR930019207A (ko) 카르니틴 결핍 hiv-혈청양성 환자 치료용 l-카르니틴의 용도
DE69109933T2 (de) Verwendung von Mizoribin zur Behandlung oder Vorbeugung der Multiplen Sklerose.
Aiello et al. Evaluation of efficacy, tolerableness and safety of Enalapril(in single daily dose in patients with mild essential hypertension).
SU1807595A1 (ru) Средство для лечения отравлений ртутью
UA29943A (uk) Спосіб лікування хворих на хронічний гепатит

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: DAICHI SUNTORY PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI ASUBIO PHARMA CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ASUBIO PHARMA CO., LTD., TOKYO, JP

8339 Ceased/non-payment of the annual fee